4.7 Article

Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 60, Issue 7, Pages 4404-4406

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00527-16

Keywords

-

Funding

  1. GlaxoSmithKline (GSK
  2. Collegeville, PA, USA)
  3. Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority [HHSO100201300011C]
  4. GSK

Ask authors/readers for more resources

Gepotidacin, a novel triazaacenaphthylene antibacterial agent, is the first in a new class of type IIA topoisomerase inhibitors with activity against many biothreat and conventional pathogens, including Neisseria gonorrhoeae. To assist ongoing clinical studies of gepotidacin to treat gonorrhea, a multilaboratory quality assurance investigation determined the reference organism (N. gonorrhoeae ATCC 49226) quality control MIC range to be 0.25 to 1 mu g/ml (88.8% of gepotidacin MIC results at the 0.5 mu g/ml mode).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014-2016

Leonard R. Duncan, Caitlin J. Smith, Robert K. Flamm, Rodrigo E. Mendes

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)

Article Microbiology

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018

Michael A. Pfaller, Michael D. Huband, Dee Shortridge, Robert K. Flamm

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Microbiology

In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates

Michael D. Huband, Rodrigo E. Mendes, Michael A. Pfaller, Jill M. Lindley, Gregory J. Strand, Vincent J. Benn, Jay Zhang, Li Li, Min Zhang, Xiaojuan Tan, Qingmei Liu, Robert K. Flamm

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Infectious Diseases

Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America

Helio S. Sader, Cecilia G. Carvalhaes, Jennifer M. Streit, Mariana Castanheira, Robert K. Flamm

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Infectious Diseases

Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015-2017)

Leonard R. Duncan, Helio S. Sader, Michael D. Huband, Robert K. Flamm, Rodrigo E. Mendes

MICROBIAL DRUG RESISTANCE (2020)

Article Microbiology

Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018

Robert K. Flamm, Leonard R. Duncan, Kamal A. Hamed, Jennifer Smart, Rodrigo E. Mendes, Michael A. Pfaller

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Infectious Diseases

Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms

Rodrigo E. Mendes, Michael D. Huband, Jennifer M. Streit, Mariana Castanheira, Robert K. Flamm

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

Article Immunology

Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients

Paul G. Ambrose, Sujata M. Bhavnani, David R. Andes, John S. Bradley, Robert K. Flamm, Jason M. Pogue, Ronald N. Jones

OPEN FORUM INFECTIOUS DISEASES (2020)

Article Infectious Diseases

Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012-18

Helio S. Sader, Cecilia G. Carvalhaes, Leonard R. Duncan, Robert K. Flamm, Dee Shortridge

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Article Infectious Diseases

Activity of ceftolozane-tazobactam and comparators when tested against bacterial surveillance isolates collected from patients at risk of infections caused by resistant gram-negative pathogens

Michael A. Pfaller, Dee Shortridge, S. J. Ryan Arends, Leonard R. Duncan, Jennifer M. Streit, Robert K. Flamm

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

Article Infectious Diseases

Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods

S. J. Ryan Arends, Michele A. Canino, Rodrigo Mendes, Nicole E. Scangarella-Oman, Robert K. Flamm

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

No Data Available